Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Friday, 27 February 2026 12:00 AM EOD	Asian-Paints2376.25	Hind-Unilever2338.25	ITC313.60	Trent3900.15	Larsen-and-Toubro4280.55	M-and-M3399.90	Reliance-Industries1394.30	Tata-Steel212.35	Titan-Company4328.40	SBI1202.00	Bharat-Electron444.45	Kotak-Mah-Bank415.30	Infosys1299.95	Bajaj-Finance996.50	Sun-PharmaInds1738.10	HDFC-Bank887.40	TCS2636.40	ICICI-Bank1379.00	Power-Grid-Corpn298.75	Maruti-Suzuki14869.55	Axis-Bank1383.85	HCL-Technologies1390.20	NTPC381.85	Bharti-Airtel1879.75	Tech-Mahindra1357.25	Adani-Ports1520.85	UltraTech-Cem12680.25	Bajaj-Finserv1992.70	Interglobe-Aviat4823.05	Eternal246.45
15 mins delay SENSEX 81,287.19 [-961.42]	-18.75 -0.78%	-45.40 -1.90%	-4.60 -1.45%	42.40 1.10%	-5.35 -0.12%	-84.15 -2.42%	-11.15 -0.79%	-3.15 -1.46%	-12.85 -0.30%	-7.20 -0.60%	-4.55 -1.01%	-9.25 -2.18%	10.60 0.82%	-16.25 -1.60%	-46.50 -2.61%	-11.45 -1.27%	-11.30 -0.43%	-25.95 -1.85%	-4.75 -1.57%	-343.50 -2.26%	-10.85 -0.78%	16.75 1.22%	0.00 0.00%	-48.75 -2.53%	-4.55 -0.33%	-29.75 -1.92%	-253.85 -1.96%	-48.65 -2.38%	-114.40 -2.32%	0.05 0.02%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Aurobindo Pharma arm receives 4 observations after US FDA inspection

28-Feb-26 14:13Hrs IST

The facility (Unit-I), located at Kolthur Village, Shameerpet Mandal, Ranga Reddy, Telangana, was inspected from 16 February to 27 February 2026, and the inspection concluded with four observations. The company said it will respond to the US FDA within the stipulated timelines.

The company confirmed there is no impact on its financials or operations due to the inspection. Aurobindo Pharma stated its commitment to maintaining high-quality manufacturing standards across all its facilities worldwide and said it will update the stock exchanges if there is any further information.

Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.

The company's consolidated net profit rose 7.6% to Rs 910.29 crore on a 9% increase in net sales to Rs 8,604.51 crore in Q3 FY26 over Q3 FY25.

Shares of Aurobindo Pharma shed 0.04% to end at Rs 1,221.55 on the BSE on Friday.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise